These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33300570)

  • 1. Urine Concentration Does Not Affect Biochemical Testing for Non-adherence.
    Burns AD; Alghamadi R; Iqbal A; Davies T; Lane D; Patel P; Gupta P
    J Anal Toxicol; 2021 Mar; 45(3):e1-e5. PubMed ID: 33300570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring adherence to antihypertensive medication using an objective test in older adults attending primary care: cross-sectional study.
    Sheppard JP; Albasri A; Gupta P; Patel P; Khunti K; Martin U; McManus RJ; Hobbs FDR
    J Hum Hypertens; 2022 Dec; 36(12):1106-1112. PubMed ID: 34876657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes.
    Patel P; Gupta P; Burns A; Suwaidan AA; Cole R; Lane D; Seidu S; Khunti K
    Diabetes Care; 2019 Jun; 42(6):1132-1135. PubMed ID: 30885952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Medication Stability in Urine for Non-Adherence Screening by LC-MS-MS.
    Burns AD; Lane D; Cole R; Patel P; Gupta P
    J Anal Toxicol; 2019 May; 43(4):325-329. PubMed ID: 30517637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel 'Dilute-and-Shoot' Liquid Chromatography-Tandem Mass Spectrometry Method for the Screening of Antihypertensive Drugs in Urine.
    Lawson AJ; Shipman KE; George S; Dasgupta I
    J Anal Toxicol; 2016; 40(1):17-27. PubMed ID: 26333988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis.
    Ritscher S; Georges C; Wunder C; Wallemacq P; Persu A; Toennes SW
    Blood Press; 2020 Oct; 29(5):291-298. PubMed ID: 32400211
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence.
    Richter LHJ; Jacobs CM; Mahfoud F; Kindermann I; Böhm M; Meyer MR
    Anal Chim Acta; 2019 Sep; 1070():69-79. PubMed ID: 31103169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessment.
    Punt AM; Stienstra NA; van Kleef MEA; Lafeber M; Spiering W; Blankestijn PJ; Bots ML; van Maarseveen EM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():103-110. PubMed ID: 31146083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct assessment of adherence and drug interactions in patients with hypertensive crisis-A cross-sectional study in the Emergency Department.
    Wallbach M; Lach N; Stock J; Hiller H; Mavropoulou E; Chavanon ML; Neurath H; Blaschke S; Lowin E; Herrmann-Lingen C; Müller GA; Koziolek MJ
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):55-63. PubMed ID: 30515967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
    Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
    J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring Antihypertensive Medication Adherence by Liquid Chromatography-Tandem Mass Spectrometry: Method Establishment and Clinical Application.
    Wang Y; Wang JW; Wang Y; Yang B; Yinghua Du A; Kong Z; Chen M; Wang J
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):581-596. PubMed ID: 34269698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatinine in urine - a method comparison.
    Luginbühl M; Weinmann W
    Drug Test Anal; 2017 Oct; 9(10):1537-1541. PubMed ID: 28102586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High non-adherence rates to secondary prevention by chemical adherence testing in patients with TIA.
    Lane D; Beishon L; Sharma V; Salim F; Sze S; Timmins MA; Robinson T; Eveson D; Mistri A; Patel P; Gupta P
    J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106665. PubMed ID: 35901588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paper Spray Ionization Coupled to High Resolution Tandem Mass Spectrometry for Comprehensive Urine Drug Testing in Comparison to Liquid Chromatography-Coupled Techniques after Urine Precipitation or Dried Urine Spot Workup.
    Michely JA; Meyer MR; Maurer HH
    Anal Chem; 2017 Nov; 89(21):11779-11786. PubMed ID: 29022692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.